Company Pharmadax Inc.

Equities

4191

TW0004191002

Biotechnology & Medical Research

Business Summary

Managers

Members of the board

Share class

Company contact information

Sector

Sector Other Biotechnology & Medical Research

Inactive Instrument

Pharmadax Inc is a Taiwan-based company principally engaged in the development, licensing and sales of Abbreviated New Drug Application (ANDA) drugs. The Company is mainly engaged in the development of oral solid extended-release dosage forms and products. The Company's main product is the hypoglycemic product, Glyburide. The Company distributes its products to the United States.

Managers	Title	Age	Since
Hsing Mei Ti DFI	Director of Finance/CFO	-	01/16/01
Hui Ju Chan PSD	President	-	01/12/01
Su Hsia Liao PRN	Corporate Officer/Principal	-	01/10/01

Members of the board	Title	Age	Since
Yao Tang Chung BRD	Director/Board Member	-	27/13/27
Hui Ju Chan PSD	President	-	01/12/01
Hung Chi Huang BRD	Director/Board Member	-	24/12/24
Kuang Yang Hsu BRD	Director/Board Member	-	27/19/27
Nan Mou Pei BRD	Director/Board Member	-	19/18/19
Xin Li BRD	Director/Board Member	-	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	88,265,000	49,754,266 ( 56.37 %)	0	56.37 %

PharmaDax Inc.

5/F-1 No. 236 Liancheng Road

235 53, New Taipei

http://www.pharmadax.com

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
MODERNA, INC.	+17.96%	44.96B
IQVIA HOLDINGS INC.	+1.17%	42.65B
LONZA GROUP AG	+48.77%	41.85B
CELLTRION, INC.	-4.27%	29.04B
ICON PUBLIC LIMITED COMPANY	+11.42%	26.08B
ALNYLAM PHARMACEUTICALS, INC.	-21.39%	19.03B
BIO-TECHNE CORPORATION	+4.86%	12.75B
MEDPACE HOLDINGS, INC.	+27.29%	12.06B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3.50%	11.75B

Other Biotechnology & Medical Research